Skip to main content
Submit keywords
Search the site
Columbia University in the City of New York
Toggle search
Columbia University
Columbia | Technology Ventures
Toggle search
Main navigation expanded
For Inventors
For Industry
Search Available Technologies
Lab-to-Market
About CTV
Forms
News and Events
Media
Submit an Invention Report
Inventors' Guide
Develop Your Innovation
Start a Company
SBIR/STTR Funding Support
IP and Entrepreneurship Language for Grant Applications
Columbia Lab-to-Market Accelerator Network
Request a Material Transfer or Confidentiality Agreement
Review Inventor Policies
Executives in Residence
Funding Opportunities
Columbia Commercialization & Entrepreneurial Resources
Faculty Ambassadors
Search Available Technologies
Software Express Licenses
Columbia Startups
Collaborate With Columbia Researchers
Start the Licensing Process
Columbia Startup Fellows Program
Featured Startup Investment Opportunities
VC and Tech Transfer Template for an Early-Stage Life-Science Startup License
AI Technologies
Technology Transfer at Columbia
A Virtuous Cycle
CTV Fellows Program
Meet Our Team
Careers
Invention Report Form
Material Transfer Agreement Forms
CDA/NDA Request Form
Sponsored Research Agreement
Faculty Handbook IP Policy
News
Events
CTV Innovation-to-Impact Series
Subscribe
Podcast
Videos
Columbia | Technology Ventures
You are here:
Home
RENBIO
RENBIO
RenBio Completes $24 Million Series A Financing and Licenses Novel SARS-CoV-2 Bispecific Antibody from Columbia University
Keyword filter:
Item
s
edit {{ item.type | lowercase }}
There are no tagged items with the provided keywords.
Back to Top